Clinical application of immediate surgical resection after interventional embolization in treating hypervascular nasal skull base tumors
10.3969/j.issn.1008-794X.2024.12.007
- VernacularTitle:鼻颅底富血供肿瘤栓塞后即刻切除术临床应用
- Author:
Yu HE
1
;
Qiang LIU
;
Rujian HONG
;
Jiawei WU
;
Siyu WANG
;
Houyong LI
;
Hongmeng YU
;
Dehui WANG
;
Yan SHA
Author Information
1. 200031 上海 复旦大学附属眼耳鼻喉科医院放射科
- Keywords:
intervention;
embolization;
immediate surgical resection;
hypervascular nasal skull base tumor
- From:
Journal of Interventional Radiology
2024;33(12):1302-1307
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the application of immediate resection after interventional embolization in treating hypervascular nasal skull base tumors.Methods The clinical data of 25 patients with hypervascular nasal skull base tumors,who were treated at the Affiliated Eye ENT Hospital of Fudan University of China from December 2020 to June 2022,were retrospectively analyzed.All patients underwent tumor surgical resection immediately after interventional embolization on the same day of admission.The success rate of embolization,incidence of complications,amount of blood loss during resection,tumor resection condition and prognosis were analyzed.Results Successful immediate surgical resection after interventional embolization was accomplished in all the 25 patients.Arterial approach was used for the interventional embolization,which was successfully performed under general anesthesia(n=19)or local anesthesia(n=6).No embolization-related complications occurred.The tumor resection was successfully accomplished under nasal endoscopy,endoscopy-guided translabial-gingival crevicular incision,or under oral endoscopy.No resection-related complications occurred.The median amount of blood loss during resection was 844 mL(range of 100-2 000 mL).Conclusion For the treatment of hypervascular nasal skull base tumors,immediate surgical resection after interventional embolization is clinically safe and feasible,and this therapeutic method is worthy of clinical promotion.
